James P. Daubert, M.D.

Viewing information for Patients. See information for Researchers.

Dr. Daubert is an Associate Professor of Medicine and Director of the Heart Rhythm Program. He joined the University of Rochester faculty in 1992 after completing training in cardiology and electrophysiology at Duke University Medical Center.In addition to general electrophysiology, his clinical specialties include:

Catheter ablation of atrial fibrillation, ventricular tachycardia, supraventricular tachycardia, Wolff-Parkinson-White, using radiofrequency and cryoenergy

Hereditary arrhythmias (Long QT Syndrome, Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D), etc.)

Cardiac resynchronization therapy (bi-ventricular pacing)

Sudden cardiac death prevention

Pacemaker and ICD lead extraction (removal of chronic leads)

With his colleagues Drs. Huang, Rosero, and Hall, Dr. Daubert staffs a busy Electrophysiology (EP) Laboratory in which all of the above procedures, including pacemaker and ICD implants, are performed. The EP Laboratory currently performs approximately 2,200 procedures, including catheter ablations, ICD implants, bi-ventricular ICD implants, EP studies, and other invasive procedures; these totals include over 400 catheter ablation procedures per year. Other critical members of the team include specialized EP lab nurses, EP fellows and rotating cardiology fellows, EP technicians, EP nurse practitioners, research coordinators, pacemaker technicians, and secretarial staff. The lab is expanding to a third dedicated EP Laboratory with remote magnetic catheter navigation capability.

Dr. Daubert and the EP Laboratory are involved with a number of clinical research projects. Dr. Daubert has served on the Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) series of landmark clinical trials, including the recently completed MADIT II trial, which demonstrated a survival advantage in patients receiving the implantable defibrillator as compared with state-of-the-art CHF management. The Executive Committee has designed and recently begun a third trial in this series, MADIT-CRT, that is looking at the role of cardiac resynchronization therapy in patients with less advanced congestive heart failure. Two active clinical trials focus on new catheters for ablation of atrial fibrillation, using freezing with cryoablation and saline irrigated radiofrequency ablation, respectively. New mapping and ablation catheter and ICD device investigations as well as antiarrhythmic medication investigations are conducted. The University of Rochester is one of the lead enrollers in an NIH-sponsored Registry of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D). Other recent NIH-sponsored studies have examined non-invasive and invasive diagnosis of Long QT syndrome (LQTS), and novel therapies for LQTS. Dr. Daubert's basic research training included computerized mapping of arrhythmias and defibrillation mechanisms. The EP Laboratory is also involved with animal laboratory investigations of prototype catheters and other devices.